ストックスクリーナーアプリを入手
11.19
1.32%
-0.15
プレマーケット:
11.22
0.03
+0.27%
Indivior Plc (INDV) 最新ニュース
Indivior to Participate in Upcoming Investor Events - Bluefield Daily Telegraph
Indivior to Participate in Upcoming Investor Events | INDV Stock News - GuruFocus
Indivior announces participation in investor conferences By Investing.com - Investing.com India
Indivior to Engage with Investors at Key Healthcare Conferences - TipRanks
Drug Addiction Treatment Market Projected To Witness Massive - openPR.com
(INDV) Long Term Investment Analysis - news.stocktradersdaily.com
Drug Abuse Treatment Market Grows Amid Rising Substance Abuse - openPR.com
Indivior advances GABA-B PAM program for substance use disorders through IND-enabling studies - BioWorld MedTech
Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies - marketscreener.com
Shareholders of Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - ACCESS Newswire
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Indivior PLC (INDV) - ACCESS Newswire
Indivior PLC Announces AGM Results with Key Resolutions Passed - TipRanks
Indivior PLC Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights – INDV - ACCESS Newswire
Indivior PLC announces leadership and bylaw changes - Investing.com Australia
Indivior PLC announces leadership and bylaw changes By Investing.com - Investing.com Nigeria
Indivior PLC Announces Successful AGM Resolutions - TipRanks
Naloxone Market Set to Witness Significant Growth by 2025-2032 | - openPR.com
Investors who lost money on Indivior PLC (INDV) should contact Levi & Korsinsky about pending Class ActionINDV - ACCESS Newswire
Decoding Indivior PLC (INDV): A Strategic SWOT Insight - GuruFocus
Shareholders that lost money on Indivior PLC (INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
When (INDV) Moves Investors should Listen - news.stocktradersdaily.com
New Study Highlights Monthly SUBLOCADE® as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy - The Malaysian Reserve
INDIVIOR PLC SEC 10-Q Report - TradingView
Indivior PLC Announces Total Voting Rights and Share Capital Update - TipRanks
Opioid Antagonist Market Is Booming Worldwide 2025-2032 | - openPR.com
Drug Detoxification Market Is Booming Worldwide 2025-2032 | - openPR.com
Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder | DelveInsight - GlobeNewswire Inc.
Indivior: Trying To Break Addiction (NASDAQ:INDV) - Seeking Alpha
Results: Indivior PLC Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
Indivior PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Indivior to release Q4 and full-year 2024 results on Feb 20 - MSN
Indivior Reports Q1 2025 Results, Maintains FY Guidance Amid Market Challenges - MSN
Indivior PLC (INDV) Trading 3.9% Higher on Apr 25 - GuruFocus
Indivior Announces Q1 2025 Financial Results - The Malaysian Reserve
Indivior Faces Revenue Challenges Amid Competitive Pressures - TipRanks
Indivior Q1 2025 Earnings Call Transcript - MarketBeat
Indivior (INDV) Q1 2025 Earnings Call - Mitrade
FTSE 250 movers: Indivior surges; Inchcape slips - Sharecast.com
Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Indivior PLC Q1 2025 Earnings: EPS of $0.38 Beats Estimate, Revenue Hits $266 Million - GuruFocus
Indivior Q1 2025 Financial Results - TradingView
Indivior (INDV) Surpasses Q1 Revenue Projections with $266M Repo - GuruFocus
Indivior shares surge following robust Q1 revenue and positive outlook By Investing.com - Investing.com Nigeria
Despite downturn, Indivior financials beat consensus - The Pharma Letter
1.38%
1.22%
大文字化:
|
ボリューム (24 時間):